We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

1 hedge funds and large institutions have $159K invested in Array Biopharma Inc in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 316 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 318 → 1 (-317)

100% less funds holding in top 10

Funds holding in top 10: 28 → 0 (-28)

100% less capital invested

Capital invested by funds: $10.5B → $159K (-$10.5B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 316

Holders
1
Holders Change
-317
Holders Change %
-99.69%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-28
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
316
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$943M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$890M
3
BlackRock
BlackRock
New York
-$824M
4
RG
Redmile Group
California
-$405M
5
FCM
Farallon Capital Management
California
-$394M
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
51
Candriam SCA
Luxembourg
– -$45.8M -992,510 Closed
Bank of New York Mellon
52
Bank of New York Mellon
New York
– -$45.2M -975,210 Closed
CC
53
Carlson Capital
Texas
– -$43.9M -947,234 Closed
GF
54
Gabelli Funds
New York
– -$42.3M -913,212 Closed
VOYA Investment Management
55
VOYA Investment Management
Georgia
– -$42.2M -910,206 Closed
Alyeska Investment Group
56
Alyeska Investment Group
Illinois
– -$41.3M -891,682 Closed
Assenagon Asset Management
57
Assenagon Asset Management
Luxembourg
– -$41.2M -888,960 Closed
KLCMU
58
Kite Lake Capital Management (UK)
United Kingdom
– -$40.2M -867,600 Closed
PA
59
Pinnacle Associates
New York
– -$38.8M -837,563 Closed
MP
60
Manikay Partners
New York
– -$37.7M -813,934 Closed
Handelsbanken Fonder
61
Handelsbanken Fonder
Sweden
– -$36.9M -795,712 Closed
SAM
62
Sectoral Asset Management
Quebec, Canada
– -$36.8M -794,868 Closed
Bank of America
63
Bank of America
North Carolina
– -$35.8M -772,474 Closed
Man Group
64
Man Group
United Kingdom
– -$31.5M -680,000 Closed
VI
65
Versor Investments
New York
– -$29.6M -638,819 Closed
BHMP
66
Bardin Hill Management Partners
New York
– -$28.1M -605,879 Closed
Canada Pension Plan Investment Board
67
Canada Pension Plan Investment Board
Ontario, Canada
– -$27.6M -596,114 Closed
Allianz Asset Management
68
Allianz Asset Management
Germany
– -$27.5M -592,903 Closed
ZDA
69
Zweig-DiMenna Associates
New York
– -$27.4M -590,640 Closed
Barclays
70
Barclays
United Kingdom
– -$27.2M -586,743 Closed
Susquehanna International Group
71
Susquehanna International Group
Pennsylvania
– -$26.9M -581,140 Closed
Two Sigma Investments
72
Two Sigma Investments
New York
– -$26.8M -578,782 Closed
PCM
73
Prelude Capital Management
New York
– -$26.1M -564,244 Closed
CCI
74
Columbus Circle Investors
– -$25.7M -553,980 Closed
LP
75
LMR Partners
United Kingdom
– -$25.3M -546,443 Closed
1 2
3
4 5

ARRY Hedge Fund Activity: Q3 2019 in Review

1 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q3 2019, worth a combined $159K — down 100% from $10.5B a quarter earlier.

Sellers outnumbered buyers: 316 funds closed out of ARRY and 0 opened new positions — a net loss of 316 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $943M sold.

  • 1 institutional investor held Array Biopharma Inc (ARRY) as of Q3 2019, down from 318 in Q2 2019.
  • Funds reported $159K of Array Biopharma Inc stock for Q3 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Array Biopharma Inc positions in Q3 2019 and 316 closed out, a net change of -316 holders.
  • The largest Array Biopharma Inc seller in Q3 2019 was Vanguard Group, an estimated $943M sold.

Based on aggregated 13F filings for Q3 2019.